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Femalegenitalschistosomiasis(FGS) is anisolatedchronic formofschistosomiasis.Althoughmostinfections occur inresidents of
endemic areas, it hasbeen clearly documented thatbrief freshwater exposure is suﬃcientto establish infection;thus,travellers may
also be infected. The clinical manifestationsof FGS are nonspeciﬁc, and lesions may mimic any neoplastic or infectious process in
the femalegenitaltract. It is importantto takea careful historyand physicalexamination,makingsure to considertravel historyin
endemicareas.The diagnosisis conﬁrmedby microscopywithegg identiﬁcation orby serology. The standardof carefortreatment
is a single dose of oral praziquantel which avoids complications and substantial morbidity. Herein, we report a rare and original
case of FGS in a European woman.
1.Introduction
Schistosomiasis was ﬁrst described by Theodor Bilharz in
1851 [1]. It is estimated that more than 200 million people
worldwide have schistosomiasis and that the infection is
responsible for more than 200,000 deaths annually [2].
Environmental changes that result from the development of
waterresourcesandthegrowthandmigrationofpopulations
can facilitate the spread of schistosomiasis [1]. Although
most infections occur in residents of endemic areas, it has
been clearly documented that brief freshwater exposure is
suﬃcient to establish infection; thus, travellers may also
be infected [3]. There is no accurate information about
infection rates among returned travellers and immigrants
because it is a rare disease in western countries [1]. Herein,
we report a rare case of female genital schistosomiasis (FGS)
in a European woman.
2.CaseReport
A European 20-year-old woman was referred from our
mucous clinic with a history of a vulvar mass evolving
for three weeks. Her past medical and surgical history was
unremarkable. This mass was painful and was increased in
size. The patient went to Senegal and Mali three months ago,
and she had a history of swimming in fresh water lakes in
these countries.Clinically,we observedaswelling oftheright
labium minus (Figure 1). This mass was painful with a soft
consistency. No other cutaneous or genital lesion was found.
She had no fever, urticarial rash, angioedema, dry cough,
or wheeze. No hematuria and no dysuria were reported.
Hepatomegaly and splenomegaly were absent. Following
laboratory parameters were within normal limits: complete
blood cell count, serum electrolyte proﬁle, and liverfunction
tests. No antischistosomal antibodies were found in the
serum, and there was no eosinophilia. Microscopy of urine
and stools was negative for ova, cysts, and parasites and did
not contain red blood cellsor white blood cells. Biopsy ofthe
vulvar lesion was made.
Histological examination at low-power view revealed a
noncaseating granulomatous reaction to clusters of viable-
appearing eggs in the dermis (Figure 2). The granuloma was
composed of epitheloid histiocytes and a lot of eosinophils
and plasma cells surrounded by a rim of lymphocytes
(Figure 3). The epidermis was moderately acanthotic with
hyperkeratosis. We observed foci of spongiosis and exocyto-
sis in front of the inﬁltrate. At high-power view, histology
revealed numerous schistosome ova with terminal spines,2 ISRN Obstetrics and Gynecology
Figure 1: Clinically, we observed a swelling of the right labium
minus.
Figure 2: A noncaseating granulomatous reaction to clusters of
viable-appearing eggs in the dermis (Haematoxylin-eosin ×100).
characteristic of Schistosoma haematobium.T h eo v ac o n -
tained multiple viable miracidia surrounded by a marked
granulomatous inﬂammatory inﬁltrate (Figure 4). The diag-
nosis proposed was FGS. The patient was treated with oral
praziquantel at a dose of 2400 mg for one day. She came
back to our clinic six months later with disappearance of the
vulvar lesion, and no others symptoms were reported.
3.Discussion
Schistosomiasis is the infection of humans by trematodes
(a class of helminths). Three major species of schistosomes
are described: S. haematobium, S. japonicum,a n dS. mansoni
[4]. S. haematobium infection is acquired predominantly
in North Africa, sub-Saharan Africa, the Middle East,
Turkey, and India. The majority of S. mansoni infections
are found in sub-Saharan Africa. S. japonicum infection
still occurs in China, Indonesia, and the Philippines [1, 5].
Morphologically, S. haematobium ova have a spine in the
apical position, whereas the spine of S. mansoni ova is on the
lateral aspect, and S. japonicum ova have no spine [5]. FGS is
theisolatedchronic formofgenitalschistosomiasis. Noother
symptom is reported. S. haematobium is the organism most
often identiﬁed in FGS [1, 4, 6]. In most cases, the lesions
Figure 3: The granulomais composed ofepitheloid histiocytes and
a lot of eosinophils and plasma cells (Haematoxylin-eosin ×200).
Figure 4: Histology revealed numerous schistosome ova with
terminal spines (arrow) characteristic of Schistosoma haematobium
(Haematoxylin-eosin ×400).
are found on the labia majora [6]. Isolated internal genital
disease is less frequent [1]. In postmortem studies of the
reproductive tract in endemic areas, ova are found in the
vulva in 7 to 17% of cases [7].
The life cycle of schistosomiasis is complex and requires
both intermediate and deﬁnitive hosts. When eggs excreted
from infected humans contaminate bodies of fresh water,
theyhatch torelease free-swimming miracidia, which in turn
infect snails, the intermediate hosts. The miracidia mature
inside the snails to become cercariae, which are released
back into the water and can penetrate the skin of humans.
Cercariae can survive up to 48 hours in water but are most
infectious to humans in the ﬁrst few hours after release from
the snail. Cercariae pass via the lung and the liver into the
portal venous and then mature into adult worms and unite.
Pairs of worms then migrate to the superior mesenteric veins
(in the case of S. mansoni), the inferior mesenteric and supe-
rior haemorrhoidal veins(in the case of S. japonicum), orthe
vesical plexus and veins draining the ureters and the urinary
bladder (in the case of S. haematobium). Live schistosome
eggs are excreted in the feces (in the case of S. mansoni
and S. japonicum)o ru r i n e( i nt h ec a s eo fS. haematobium).ISRN Obstetrics and Gynecology 3
Direct retrograde spread ofthe adult worms from their usual
sites into the venous system supplying vulvar skin leads to
deposition of ova in the skin and subsequent formation of
genital lesions, as in our patient. The life cycle is completed
when the eggs hatch, releasing miracidia that, in turn, infect
speciﬁc freshwater snails [1, 4, 5]. The adult worms remain
in the blood vessels for life and survive for ﬁve to seven years
and can even persist for up to 30 years [8].
Physiopathologically, 2 to 3cm adult worms may cause
venous obstruction where they reside, but the disease is
m o r ec o m m o n l yca u s e db yth ed a i l yd e p o s i ti o no fn u m e r o u s
eggs by the female (hundreds to thousands eggs per day,
depending on the species), which invades local tissues,
where they release toxins and enzymes and provoke a TH-
2-mediated immune response [4, 8, 9]. Inﬂammation and
granuloma formation occur around deposited eggs, which
can lead to extensive tissue damage (ﬁbrosis and scarring)
[4, 10]. Most patients infected with schistosomes of all
species are asymptomatic. Acute symptoms tend to be more
common in nonimmune individuals, such as travellers, due
toa more intense immune response toexposure. Bycontrast,
chronic complications require a higher burden of infection
and, thus, are mainly seen in individuals from endemic areas
[11]. The clinical picture of genital schistosomiasis and the
pathological ﬁndings vary according to the organ aﬀected.
The clinical manifestations of FGS are nonspeciﬁc except
the presence of sandy patches (areas of roughened mucosa
surrounding egg deposits) on the cervical surface [7, 12]. It
can include irregular bleeding, discharge, pelvic pain or ten-
derness, dyspareunia, and otherwise unexplained infertility.
The lesions are polypoid or papillomatous tumorlike lesions
on the vaginal wall and vulva. Macroscopically, lesions
in FGS may mimic any neoplastic or infectious process
(e.g., condyloma lata, syphilis, squamous cell carcinoma)
in the female genital tract [1, 4, 13]. Lesions of the vulva
and clitoris vary in size and presentation. Progressive and
relapsing swelling, painful or painless ulceration, nodular
surface, pruritus, and a hypertrophic clitoris with an eroded
granularsurfacehavebeendescribed.Genitalschistosomiasis
started with an irritation of the skin, followed by oedema
and hyperaemia. Later small nodules developed under the
skin and papillomatous lesions appeared forming masses
resembling condylomata [14]. In travellers returning from
the tropics, due to the unspeciﬁc nature of gynaecological
ﬁndings, delays of more than 24 months in diagnosis
have been reported, the lesions being misdiagnosed as, for
example, vulval warts [14].
The diagnosis of FGS is ﬁrst suspected after taking a
careful history and physical examination, making sure to
consider travel history in endemic areas. It can be conﬁrmed
by microscopy with egg identiﬁcation or by serology [4,
15]. Eggs can be directly visualized in urine or feces, but
this test has limited use in the diagnosis of FGS, because
FGS may exist independently and without signs of urinary
schistosomiasis [4, 14, 16]. Studies in S. haematobium-
endemic areas have also shown that up to 23% of women
may have involvement of the lower reproductive tract even
without schistosome ova in the urine [7].
The complications with S. haematobium are granulo-
matous inﬂammation, ulceration of the vesical and ureteral
walls with subsequent ﬁbrosis, functional bladder neck ob-
struction, hydroureter, hydronephrosis, and calciﬁcations of
the urinary tract and bladder. Genital involvement can cause
infertility secondary to ovarian ﬁbrosis or tubal occlusion.
S. haematobium could be a cofactor for the development of
cervical cancer and squamous cell carcinoma of the bladder,
but a clear link has yet to be established. Finally, FGS may
also facilitate the transmission of human immunodeﬁciency
virus [1, 4, 7, 12, 16].
The standard of care for treatment is a single dose of oral
praziquantel, a pyrazinoisoquinoline derivative, at a dose of
40mg/kg[1,4,13].Thedrug’spreciseactiononadultworms
is unknown. Although praziquantel is not considered to be
teratogenic or mutagenic, the drug is not recommended in
pregnancy or in lactating women [14]. Reexamination of
feces or urine one month after treatment is recommended
in order to assess eﬃcacy [1]. In our patient, this control is
useless because the urinary and feces tests were already nega-
tivebefore thetreatment. Meltzeretal.proposeto screenand
treat asymptomatic travellers with history of freshwater ex-
posure in endemic countries [17].
In conclusion, female genital schistosomiasis is a rare
disease in the western world. Our patient illustrates an un-
usual presentation of schistosomiasis via the localisation of
the lesion and the patient’s origin. It should be born in mind
as a cause of granulomatous inﬂammation on the genitalia
andmustenterintothediﬀerentialdiagnosisofsymptomatic
genital lesions when the clinical history indicates travel in
endemic areas. Eggs can be identiﬁed by cytologic or his-
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